This Article Full Text Full Text (PDF) Submit a related Letter to the Editor Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Copyright Permission Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Ahrens, W. Articles by Kruse, K. Search for Related Content PubMed PubMed Citation Articles by Ahrens, W. Articles by Kruse, K.

Analysis of the GNAS1 Gene in Albright’s Hereditary Osteodystrophy

Department of Pediatrics, Medical University of Lübeck, Lübeck, Germany

Address all correspondence and requests for reprints to: Wiebke Ahrens, M.D., Klinik für Kinder- und Jugendmedizin, Medizinische Universität zu Lübeck, Ratzeburger Allee 160, 23538 Lübeck, Germany. E-mail: ahrens{at}paedia.ukl.mu-luebeck.de

Abstract

Albright’s hereditary osteodystrophy (AHO) is characterized by phenotypic signs that typically include brachydactyly and sc calcifications occurring with or without hormone resistance toward PTH or other hormones such as thyroid hormone or gonadotropins. Different inactivating mutations of the gene GNAS1 encoding Gs lead to a reduced Gs protein activity in patients with AHO and pseudohypoparathyroidism type Ia or without resistance to PTH (pseudopseudohypoparathyroidism).

We investigated 29 unrelated patients with AHO and pseudohypoparathyroidism type Ia or pseudopseudohypoparathyroidism and their affected family members performing functional and molecular genetic analysis of Gs. In vitro determination of Gs protein activity in erythrocyte membranes was followed by the investigation of the whole coding region of the GNAS1 gene using PCR, nonisotopic single strand conformation analysis, and direct sequencing of the PCR products.

All patients showed a reduced Gs protein activity (mean 59% compared with healthy controls). In 21/29 (72%) patients, 15 different mutations in GNAS1 including 11 novel mutations were detected. In addition we add five unrelated patients with a previously described 4 bp deletion in exon 7 ( GACT, codon 189/190), confirming the presence of a hot spot for loss of function mutations in GNAS1. In eight patients, no molecular abnormality was found in the GNAS1 gene despite a functional defect of Gs.

We conclude that biochemical and molecular analysis of Gs and its gene GNAS1 can be valuable tools to confirm the diagnosis of AHO. However, in some patients with reduced activity of Gs, the molecular defect cannot be detected in the exons encoding the common form of Gs.

This article has been cited by other articles:

				K. Freson, B. Izzi, J. Jaeken, M. Van Helvoirt, C. Thys, C. Wittevrongel, F. de Zegher, and C. Van Geet Compound Heterozygous Mutations in the GNAS Gene of a Boy with Morbid Obesity, Thyroid-Stimulating Hormone Resistance, Pseudohypoparathyroidism, and a Prothrombotic State J. Clin. Endocrinol. Metab., December 1, 2008; 93(12): 4844 - 4849. [Abstract] [Full Text] [PDF]

				K. Freson, B. Izzi, V. Labarque, M. Van Helvoirt, C. Thys, C. Wittevrongel, M. Bex, R. Bouillon, N. Godefroid, W. Proesmans, et al. GNAS Defects Identified by Stimulatory G Protein {alpha}-Subunit Signalling Studies in Platelets J. Clin. Endocrinol. Metab., December 1, 2008; 93(12): 4851 - 4859. [Abstract] [Full Text] [PDF]

				Picture of the Month--Diagnosis Arch Pediatr Adolesc Med, November 1, 2008; 162(11): 1092 - 1092. [Full Text] [PDF]

				S. C. Hsu, J. D. Groman, C. A. Merlo, K. Naughton, P. L. Zeitlin, E. L. Germain-Lee, M. P. Boyle, and G. R. Cutting Patients with Mutations in Gs{alpha} Have Reduced Activation of a Downstream Target in Epithelial Tissues due to Haploinsufficiency J. Clin. Endocrinol. Metab., October 1, 2007; 92(10): 3941 - 3948. [Abstract] [Full Text] [PDF]

				G. P. de Nanclares, E. Fernandez-Rebollo, I. Santin, B. Garcia-Cuartero, S. Gaztambide, E. Menendez, M. J. Morales, M. Pombo, J. R. Bilbao, F. Barros, et al. Epigenetic Defects of GNAS in Patients with Pseudohypoparathyroidism and Mild Features of Albright's Hereditary Osteodystrophy J. Clin. Endocrinol. Metab., June 1, 2007; 92(6): 2370 - 2373. [Abstract] [Full Text] [PDF]

				L. F. Frohlich, M. Bastepe, D. Ozturk, H. Abu-Zahra, and H. Juppner Lack of Gnas Epigenetic Changes and Pseudohypoparathyroidism Type Ib in Mice with Targeted Disruption of Syntaxin-16 Endocrinology, June 1, 2007; 148(6): 2925 - 2935. [Abstract] [Full Text] [PDF]

				S. Thiele, R. Werner, W. Ahrens, U. Hoppe, C. Marschke, P. Staedt, and O. Hiort A Disruptive Mutation in Exon 3 of the GNAS Gene with Albright Hereditary Osteodystrophy, Normocalcemic Pseudohypoparathyroidism, and Selective Long Transcript Variant Gs{alpha}-L Deficiency J. Clin. Endocrinol. Metab., May 1, 2007; 92(5): 1764 - 1768. [Abstract] [Full Text] [PDF]

				F. G Riepe, W. Ahrens, N. Krone, R. Folster-Holst, J. Brasch, W. G Sippell, O. Hiort, and C.-J. Partsch Early manifestation of calcinosis cutis in pseudohypoparathyroidism type Ia associated with a novel mutation in the GNAS gene Eur. J. Endocrinol., April 1, 2005; 152(4): 515 - 519. [Abstract] [Full Text] [PDF]

				G. Mantovani, M. Maghnie, G. Weber, E. De Menis, V. Brunelli, M. Cappa, P. Loli, P. Beck-Peccoz, and A. Spada Growth Hormone-Releasing Hormone Resistance in Pseudohypoparathyroidism Type Ia: New Evidence for Imprinting of the Gs{alpha} Gene J. Clin. Endocrinol. Metab., September 1, 2003; 88(9): 4070 - 4074. [Abstract] [Full Text] [PDF]

				M. Bastepe, Y. Gunes, B. Perez-Villamil, J. Hunzelman, L. S. Weinstein, and H. Juppner Receptor-Mediated Adenylyl Cyclase Activation Through XL{alpha}s, the Extra-Large Variant of the Stimulatory G Protein {alpha}-Subunit Mol. Endocrinol., August 1, 2002; 16(8): 1912 - 1919. [Abstract] [Full Text] [PDF]

				H. Juppner The Genetic Basis of Progressive Osseous Heteroplasia N. Engl. J. Med., January 10, 2002; 346(2): 128 - 130. [Full Text] [PDF]

				L. S. Weinstein The Stimulatory G Protein {alpha}-Subunit Gene: Mutations and Imprinting Lead to Complex Phenotypes J. Clin. Endocrinol. Metab., October 1, 2001; 86(10): 4622 - 4626. [Full Text] [PDF]